A prospective, randomized study in critically ill patients using the Oligon Vantex catheter.

Area of Science:

• Infectious Diseases
• Medical Devices
• Critical Care Medicine

Background:

• Catheter-related bloodstream infections (CR-BSI) are a significant complication in critically ill patients requiring central venous catheters (CVCs).
• Microbial colonization of CVCs is a primary precursor to CR-BSI, necessitating strategies to prevent bacterial adherence and biofilm formation.

Purpose of the Study:

• To evaluate the efficacy of Oligon Vantex silver central venous catheters (CVCs) in reducing microbial colonization and CR-BSI incidence.
• To compare the outcomes of silver-impregnated CVCs against standard polyurethane CVCs in a critically ill patient population.

Main Methods:

• A prospective, randomized, controlled trial involving 206 critically ill patients requiring triple-lumen CVCs for at least four days.
• Patients were randomized to receive either a standard polyurethane CVC or an Oligon Vantex silver CVC.
• Microbial cultures of blood, skin, hub, and catheter tips were performed, alongside multivariate logistic-regression analysis to identify predisposing factors.

Main Results:

• The silver CVC group showed significantly lower rates of catheter colonization or CR-BSI (29%) compared to the control group (44%) (P=0.04).
• CR-BSI incidence per 1000 catheter-days was substantially reduced in the silver group (0.8) versus the control group (2.8) (P<0.001).
• Reduced colonization was observed with silver CVCs in specific scenarios, including shorter dwell times (≤8 days), longer dwell times (>15 days), presence of a second catheter, and internal jugular vein placement.

Conclusions:

• The Oligon Vantex silver catheter effectively reduced microbial colonization of central venous catheters in critically ill patients.
• The use of silver-impregnated CVCs demonstrated a potential to decrease the risk of catheter-related bloodstream infections, improving patient safety.